complications
CONCLUSIONS: Major       methodologic problems and sources of heterogeneity not only hamper the       comparability of trials, but also preclude a conclusion on the efficacy and       safety of BR in the adjunct treatment of patients with PD who have motor       complications.
CONCLUSIONS: Major       methodologic problems and sources of heterogeneity not only hamper the       comparability of trials, but also preclude a conclusion on the efficacy and       safety of BR in the adjunct treatment of  @OBJECT$  with PD who  @PREDICAT$  motor        @SUBJECT$ .